» Articles » PMID: 27506793

Peroxidation of Polyunsaturated Fatty Acids by Lipoxygenases Drives Ferroptosis

Overview
Specialty Science
Date 2016 Aug 11
PMID 27506793
Citations 999
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is form of regulated nonapoptotic cell death that is involved in diverse disease contexts. Small molecules that inhibit glutathione peroxidase 4 (GPX4), a phospholipid peroxidase, cause lethal accumulation of lipid peroxides and induce ferroptotic cell death. Although ferroptosis has been suggested to involve accumulation of reactive oxygen species (ROS) in lipid environments, the mediators and substrates of ROS generation and the pharmacological mechanism of GPX4 inhibition that generates ROS in lipid environments are unknown. We report here the mechanism of lipid peroxidation during ferroptosis, which involves phosphorylase kinase G2 (PHKG2) regulation of iron availability to lipoxygenase enzymes, which in turn drive ferroptosis through peroxidation of polyunsaturated fatty acids (PUFAs) at the bis-allylic position; indeed, pretreating cells with PUFAs containing the heavy hydrogen isotope deuterium at the site of peroxidation (D-PUFA) prevented PUFA oxidation and blocked ferroptosis. We further found that ferroptosis inducers inhibit GPX4 by covalently targeting the active site selenocysteine, leading to accumulation of PUFA hydroperoxides. In summary, we found that PUFA oxidation by lipoxygenases via a PHKG2-dependent iron pool is necessary for ferroptosis and that the covalent inhibition of the catalytic selenocysteine in Gpx4 prevents elimination of PUFA hydroperoxides; these findings suggest new strategies for controlling ferroptosis in diverse contexts.

Citing Articles

Taurine Attenuates Neuronal Ferroptosis by CSF-Derived Exosomes of GABABR Encephalitis Through GABABR/NF2/P-YAP Pathway.

Zhang C, Zhou T, Qiao S, Lu L, Zhu M, Wang A Mol Neurobiol. 2025; .

PMID: 40085353 DOI: 10.1007/s12035-025-04819-3.


Ferroptosis, pathogenesis and therapy in AS co-depression disease.

Zhao Y, Ren P, Luo Q, Li X, Cheng X, Wen Y Front Pharmacol. 2025; 16:1516601.

PMID: 40066336 PMC: 11891183. DOI: 10.3389/fphar.2025.1516601.


Role of environmental pollutants-induced ferroptosis in pulmonary diseases.

Yang L, Qiao Y, Huang Z, Chen Y, Zhang E, Liu Z Front Med (Lausanne). 2025; 12:1542275.

PMID: 40066170 PMC: 11891068. DOI: 10.3389/fmed.2025.1542275.


From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders.

He Y, Lin Y, Song J, Song M, Nie X, Sun H Cell Commun Signal. 2025; 23(1):125.

PMID: 40055721 PMC: 11889974. DOI: 10.1186/s12964-025-02121-2.


Inhibition of Hippocampal Neuronal Ferroptosis by Liproxstatin-1 Improves Learning and Memory Function in Aged Mice with Perioperative Neurocognitive Dysfunction.

Lin L, Ling X, Chen T, Zhou Q, Huang J, Huang L J Inflamm Res. 2025; 18:2991-3007.

PMID: 40046685 PMC: 11880682. DOI: 10.2147/JIR.S503784.


References
1.
Yang W, Stockwell B . Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol. 2008; 9(6):R92. PMC: 2481424. DOI: 10.1186/gb-2008-9-6-r92. View

2.
Jiang L, Kon N, Li T, Wang S, Su T, Hibshoosh H . Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015; 520(7545):57-62. PMC: 4455927. DOI: 10.1038/nature14344. View

3.
Volpe J . Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res. 2001; 50(5):553-62. DOI: 10.1203/00006450-200111000-00003. View

4.
Chen X, Funk C . The N-terminal "beta-barrel" domain of 5-lipoxygenase is essential for nuclear membrane translocation. J Biol Chem. 2000; 276(1):811-8. DOI: 10.1074/jbc.M008203200. View

5.
Zinoni F, Birkmann A, STADTMAN T, Bock A . Nucleotide sequence and expression of the selenocysteine-containing polypeptide of formate dehydrogenase (formate-hydrogen-lyase-linked) from Escherichia coli. Proc Natl Acad Sci U S A. 1986; 83(13):4650-4. PMC: 323799. DOI: 10.1073/pnas.83.13.4650. View